Rare diseases
Investigational molecules
Locations
Back to Germany390 clinical trials in Erlangen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments
GermanyStudy of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
GermanyStudy on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyA Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome
GermanyStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
GermanyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
GermanyStudy on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus
GermanyStudy on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease
GermanyStudy on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
GermanyStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of new therapies for HR-positive and HER2-negative variants. Additional research encompasses lung cancer and various lymphomas.
Studies evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.
Comprehensive research into various autoimmune disorders, including lupus erythematosus, psoriasis, and systemic conditions. Studies focus on innovative therapeutic approaches.
Trials aim to develop more effective treatments for chronic autoimmune conditions.
Clinical investigations focusing on acute cerebral ischemic stroke and multiple system atrophy. Research emphasizes innovative therapeutic approaches for better patient outcomes.
Studies evaluate new therapeutic agents and treatment strategies for neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
